HUE061945T2 - Heteroarilfenoxi-benzamid kappa opioid ligandumok - Google Patents

Heteroarilfenoxi-benzamid kappa opioid ligandumok

Info

Publication number
HUE061945T2
HUE061945T2 HUE17818281A HUE17818281A HUE061945T2 HU E061945 T2 HUE061945 T2 HU E061945T2 HU E17818281 A HUE17818281 A HU E17818281A HU E17818281 A HUE17818281 A HU E17818281A HU E061945 T2 HUE061945 T2 HU E061945T2
Authority
HU
Hungary
Prior art keywords
heteroarylphenoxybenzamide
kappa opioid
opioid ligands
ligands
kappa
Prior art date
Application number
HUE17818281A
Other languages
English (en)
Hungarian (hu)
Inventor
Kapildev Kashmirilal Arora
Michael Aaron Brodney
Matthew Francis Dunn
Michael Eric Green
Natasha Mariam Kablaoui
Gregory Wayne Kauffman
Scot Richard Mente
Justin Ian Montgomery
Danica Antonia Rankic
Bruce Nelsen Rogers
Patrick Robert Verhoest
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of HUE061945T2 publication Critical patent/HUE061945T2/hu

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D403/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D231/00Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
    • C07D231/02Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
    • C07D231/10Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D231/14Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D231/18One oxygen or sulfur atom
    • C07D231/20One oxygen atom attached in position 3 or 5
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D413/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
    • C07D413/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D417/00Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/02Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
    • C07D417/04Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07BGENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00Indexing scheme relating to specific properties of organic compounds
    • C07B2200/13Crystalline forms, e.g. polymorphs

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
HUE17818281A 2016-11-28 2017-11-27 Heteroarilfenoxi-benzamid kappa opioid ligandumok HUE061945T2 (hu)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201662426980P 2016-11-28 2016-11-28
US201762576435P 2017-10-24 2017-10-24
US201762585016P 2017-11-13 2017-11-13

Publications (1)

Publication Number Publication Date
HUE061945T2 true HUE061945T2 (hu) 2023-09-28

Family

ID=60782279

Family Applications (1)

Application Number Title Priority Date Filing Date
HUE17818281A HUE061945T2 (hu) 2016-11-28 2017-11-27 Heteroarilfenoxi-benzamid kappa opioid ligandumok

Country Status (18)

Country Link
US (1) US10316021B2 (enExample)
EP (1) EP3544972B8 (enExample)
JP (1) JP7051853B2 (enExample)
CN (1) CN110234638B (enExample)
AU (1) AU2017365123B2 (enExample)
DK (1) DK3544972T3 (enExample)
ES (1) ES2947293T3 (enExample)
FI (1) FI3544972T3 (enExample)
HR (1) HRP20230518T1 (enExample)
HU (1) HUE061945T2 (enExample)
IL (1) IL266962B (enExample)
MX (1) MX389806B (enExample)
PH (1) PH12019501172A1 (enExample)
PL (1) PL3544972T3 (enExample)
PT (1) PT3544972T (enExample)
RS (1) RS64258B1 (enExample)
TW (1) TWI720272B (enExample)
WO (1) WO2018096510A1 (enExample)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2018154118A2 (en) * 2017-02-24 2018-08-30 Reinmueller Viktoria Novel aromatic compounds
EP3585485A2 (en) * 2017-02-24 2020-01-01 Xeniopro GmbH Aromatic compounds which enhance notch signaling, for use in therapy
US11266627B1 (en) 2021-05-04 2022-03-08 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
CN111233768B (zh) * 2020-03-18 2021-08-03 徐州圣元化工有限公司 一种3-(二氟甲基)-1-甲基-1h-吡唑-4-羧酸乙酯的制备方法
PH12021552872A1 (en) * 2020-04-05 2022-03-21 Pfizer Compounds and methods for the treatment of covid-19
US12161622B2 (en) 2021-05-04 2024-12-10 Janssen Pharmaceuticals, Inc. Compositions and methods for the treatment of depression
PE20242109A1 (es) * 2022-03-07 2024-10-28 Janssen Pharmaceuticals Inc Formas puras de aticaprant cristalino
CA3254546A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. COMPOSITIONS CONTAINING ATICAPRANT
WO2023170550A1 (en) 2022-03-07 2023-09-14 Janssen Pharmaceuticals, Inc. Polymorph forms of aticaprant for use in treating major depressive disorder
WO2024079733A1 (en) * 2022-10-12 2024-04-18 Adama Makhteshim Ltd. Process for the preparation of aminopyridazine derivatives

Family Cites Families (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR0166088B1 (ko) 1990-01-23 1999-01-15 . 수용해도가 증가된 시클로덱스트린 유도체 및 이의 용도
US5376645A (en) 1990-01-23 1994-12-27 University Of Kansas Derivatives of cyclodextrins exhibiting enhanced aqueous solubility and the use thereof
GB9518953D0 (en) 1995-09-15 1995-11-15 Pfizer Ltd Pharmaceutical formulations
WO2000035296A1 (en) 1996-11-27 2000-06-22 Wm. Wrigley Jr. Company Improved release of medicament active agents from a chewing gum coating
GB9711643D0 (en) 1997-06-05 1997-07-30 Janssen Pharmaceutica Nv Glass thermoplastic systems
JP2000159747A (ja) * 1998-09-21 2000-06-13 Takeda Chem Ind Ltd 新規チオ―ル誘導体、その製造法および用途
CA2344412A1 (en) 1998-09-21 2000-03-30 Takeda Chemical Industries, Ltd. Thiol compound, their production and use
IT1303737B1 (it) 1998-11-11 2001-02-23 Smithkline Beecham Spa Derivati fenilpiperidinici procedimento per la loro preparazione eloro uso come ligandi del recettore orl-1.
ES2305491T3 (es) 2002-09-19 2008-11-01 Eli Lilly And Company Eteres de diarilo como antagonistas de receptores de opioides.
US7365209B2 (en) 2003-02-11 2008-04-29 Pharmacopeia, Inc. Nitrogen heterocycle biaryls for osteoporosis and other diseases
DE602004016127D1 (de) 2003-03-07 2008-10-09 Lilly Co Eli Antagonisten der opioidrezeptoren
JP4736043B2 (ja) 2003-03-14 2011-07-27 小野薬品工業株式会社 含窒素複素環誘導体およびそれらを有効成分とする薬剤
RU2416608C2 (ru) 2004-08-06 2011-04-20 Оцука Фармасьютикал Ко., Лтд. Ароматическое соединение
CN101120055B (zh) 2005-02-18 2014-07-23 日本曹达株式会社 有机无机复合体
CA2644368A1 (en) 2006-03-10 2007-09-20 Ono Pharmaceutical Co., Ltd. Nitrogenated heterocyclic derivative, and pharmaceutical agent comprising the derivative as active ingredient
HRP20100113T1 (hr) 2006-04-04 2010-04-30 Emodys Gmbh Upotreba pripravaka koji sadrže antagonist kapa-opioidnog receptora, namijenjenih liječenju disocijativnih poremećaja
JO2797B1 (en) 2008-01-22 2014-03-15 ايلي ليلي اند كومباني Selective opioid receptor antagonist kappa
JP2011512359A (ja) 2008-02-14 2011-04-21 アミラ ファーマシューティカルズ,インク. プロスタグランジンd2受容体のアンタゴニストとしての環式ジアリールエーテル化合物
CR11559A (es) 2008-03-25 2010-10-20 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
US8048895B2 (en) 2008-04-18 2011-11-01 Research Triangle Institute Kappa opioid receptor ligands
NZ589843A (en) 2008-06-27 2012-12-21 Avila Therapeutics Inc Pyrimidine heteroaryl compounds and uses thereof as protein kinase inhibitors
US8609696B2 (en) 2008-12-18 2013-12-17 Boehringer Ingelheim International Gmbh Serotonin 5-HT2B receptor inhibitors
HN2010001319A (es) 2009-01-26 2013-01-15 Lilly Co Eli Antagonista del receptor opioide selectivo kappa
WO2013059648A1 (en) 2011-10-21 2013-04-25 Neurotherapeutics Pharma, Inc. 2,3,5 trisubstituted aryl and heteroaryl amino derivatives, compositions, and methods of use
CN104684894A (zh) 2012-10-02 2015-06-03 默克专利股份有限公司 吡咯烷类
WO2015109080A1 (en) 2014-01-15 2015-07-23 Research Triangle Institute Kappa-opioid receptor selective opioid receptor antagonists
US10118896B2 (en) 2014-11-26 2018-11-06 University Of Kansas Antagonists of the kappa opioid receptor

Also Published As

Publication number Publication date
PH12019501172A1 (en) 2019-12-11
TWI720272B (zh) 2021-03-01
WO2018096510A1 (en) 2018-05-31
AU2017365123A1 (en) 2019-07-11
NZ754862A (en) 2024-11-29
TW201831460A (zh) 2018-09-01
HRP20230518T1 (hr) 2023-08-04
US10316021B2 (en) 2019-06-11
MX2019006220A (es) 2019-10-07
PT3544972T (pt) 2023-06-20
JP7051853B2 (ja) 2022-04-11
DK3544972T3 (da) 2023-05-30
CN110234638B (zh) 2022-10-21
MX389806B (es) 2025-03-20
EP3544972B8 (en) 2023-06-07
EP3544972A1 (en) 2019-10-02
CN110234638A (zh) 2019-09-13
US20180148432A1 (en) 2018-05-31
CA3045242A1 (en) 2018-05-31
AU2017365123B2 (en) 2022-02-17
IL266962B (en) 2022-02-01
JP2019535799A (ja) 2019-12-12
ES2947293T3 (es) 2023-08-04
RS64258B1 (sr) 2023-07-31
EP3544972B1 (en) 2023-04-26
PL3544972T3 (pl) 2023-07-24
FI3544972T3 (fi) 2023-06-02
IL266962A (en) 2019-07-31

Similar Documents

Publication Publication Date Title
DK3544972T3 (da) Heteroarylphenoxy-benzamid kappa opioid ligander
EP3535459A4 (en) CISTERN
EP3975204C0 (en) LIQUID BASED THREAD
EP3485794A4 (en) DISHWASHER
EP3494857A4 (en) DISHWASHER
EP3484336A4 (en) DISHWASHER
DK3325369T3 (da) Sprøjtestøbt låg
LT3464336T (lt) Junginiai
EP3563751A4 (en) DISHWASHER
EP3494859A4 (en) DISHWASHER
DK3465207T3 (da) Ligand-identificering via co-fraktionering
DE112016005368A5 (de) Matratzenbezug
EP3494858A4 (en) DISHWASHER
DK3413892T3 (da) Tetrahydroisoquinolinderivater
DE112017000734A5 (de) Glycolsensor
DE112017006386A5 (de) Schraubarbeitszylinder
EP3488757A4 (en) Dishwasher
EP3425179A4 (en) CONSTRUCTION MACHINE
EP3480298A4 (en) KIDNEY PRODUCTION PROCESS
EP3360840A4 (en) OPERATING MACHINE
ITUA20162284A1 (it) Cappuccinatore
DE112017005767A5 (de) Nasslaufende lamellenkupplung
DK3436447T3 (da) Isoquinolinyl-triazolon-komplekser
EP3449069A4 (en) IMPROVED SKIRTING STRIP
DK3383989T3 (da) Coated vasketablet